Showing results (471-480 of 594) with videos related to

Sort By:
Pageof 60
Journal of Medicinal Chemistry|February 1, 1991
A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralinC Mellin, J Vallgårda, D L Nelson, et al.
Blood|July 9, 1999
The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formationE Haddad, E Cramer, C Rivière, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Eukaryotic chromosome transfer: linkage of the murine major histocompatibility complex to an inserted dominant selectable markerJ H Weis, D L Nelson, M J Przyborski, et al.
Journal of Medicinal Chemistry|June 17, 1998
Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activityA P Monte, D Marona-Lewicka, M M Lewis, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|October 20, 1998
The radioprotective effect of a new aminothiol (20-PRA)M F Dolabela, M T Pereira, C E Salas, et al.
American Journal of Human Genetics|January 1, 1997
Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotypeT C Falik-Zaccai, E Shachak, M Yalon, et al.
The Journal of Pathology|August 26, 1998
Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndromeF Facchetti, L Blanzuoli, W Vermi, et al.
Journal of Medicinal Chemistry|September 25, 1997
Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivativesA P Monte, S R Waldman, D Marona-Lewicka, et al.
Science (New York, N.Y.)|June 21, 1991
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)nE J Kremer, M Pritchard, M Lynch, et al.
Annals of Internal Medicine|August 15, 1988
Elevated serum levels of soluble Tac peptide in adult T-cell leukemia: correlation with clinical status during chemotherapyL Marcon, L A Rubin, C C Kurman, et al.
Pageof 60